Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence
Key result
This review proposes and discusses a chronological sequence of practical questions to assist physicians in clinical decision-making for antithrombotic management in patients with AF undergoing PCI.
Why the study?
Antithrombotic management in patients with atrial fibrillation undergoing PCI involves multiple interconnected clinical decisions requiring chronological practical guidance.
How should antithrombotic therapy be managed in patients with atrial fibrillation undergoing percutaneous coronary intervention?
Population
Patients with atrial fibrillation undergoing percutaneous coronary intervention
Design
Clinical consensus review
Authors
Discussion
Loading...
Member takes
Implication
Supports sequential antithrombotic decisions in AF-PCI per 2018 consensus; leaves open prospective validation of individualized strategies.
Structured PICO
How should antithrombotic therapy be managed in patients with atrial fibrillation undergoing percutaneous coronary intervention?
P
Population
Patients with atrial fibrillation undergoing percutaneous coronary intervention
I
Intervention
Antithrombotic therapy management (including duration of initial triple therapy, selection of P2Y12 inhibitor, choice and intensity of oral anticoagulant)
Provides a practical, chronological framework for clinical decision-making regarding antithrombotic therapy in patients with AF undergoing PCI, aligned with the 2018 EHRA/ESC consensus.
Cite This Study
Rubboli et al. (2020) conducted a review in Atrial fibrillation undergoing percutaneous coronary intervention. Antithrombotic therapy was evaluated. This review proposes and discusses a chronological sequence of practical questions to assist physicians in clinical decision-making for antithrombotic management in patients with AF undergoing PCI.